These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26067436)
21. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease. Saiz-Rodríguez M; Gil-Polo C; Diez-Fairen M; Martinez-Horta SI; Sampedro Santalo F; Calvo S; Alonso-García E; Riñones-Mena E; Aguado L; Mariscal N; Muñoz-Siscart I; Piñeiro D; Rivadeneyra J; Cubo E Neurol Sci; 2022 Oct; 43(10):6079-6085. PubMed ID: 35725858 [TBL] [Abstract][Full Text] [Related]
27. Apathy is not depression in Huntington's disease. Naarding P; Janzing JG; Eling P; van der Werf S; Kremer B J Neuropsychiatry Clin Neurosci; 2009; 21(3):266-70. PubMed ID: 19776305 [TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric aspects of Huntington's disease. Paulsen JS; Ready RE; Hamilton JM; Mega MS; Cummings JL J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):310-4. PubMed ID: 11511702 [TBL] [Abstract][Full Text] [Related]
29. Spanish Validation of the Problem Behaviors Assessment-Short (PBA-s) for Huntington's Disease. Ruiz-Idiago JM; Floriach M; Mareca C; Salvador R; López-Sendón JL; Mañanés V; Cubo E; Mariscal N; Muñoz E; Santacruz P; Noguera MF; Vivancos L; Roy P; Pomarol-Clotet E; Sarró S; J Neuropsychiatry Clin Neurosci; 2017; 29(1):31-38. PubMed ID: 27417071 [TBL] [Abstract][Full Text] [Related]
30. Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. Berrios GE; Wagle AC; Marková IS; Wagle SA; Rosser A; Hodges JR Acta Psychiatr Scand; 2002 Mar; 105(3):224-30. PubMed ID: 11939977 [TBL] [Abstract][Full Text] [Related]
31. Discriminant analysis of Beck Depression Inventory and Hamilton Rating Scale for Depression in Huntington's disease. Rickards H; De Souza J; Crooks J; van Walsem MR; van Duijn E; Landwehrmeyer B; Squitieri F; Simpson SA; J Neuropsychiatry Clin Neurosci; 2011; 23(4):399-402. PubMed ID: 22231310 [TBL] [Abstract][Full Text] [Related]
32. Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients. Ruiz-Idiago J; Pomarol-Clotet E; Salvador R Parkinsonism Relat Disord; 2023 Jan; 106():105228. PubMed ID: 36470173 [TBL] [Abstract][Full Text] [Related]
33. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818 [TBL] [Abstract][Full Text] [Related]
34. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165 [TBL] [Abstract][Full Text] [Related]
38. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. Burns A; Folstein S; Brandt J; Folstein M J Nerv Ment Dis; 1990 Jan; 178(1):20-6. PubMed ID: 2136908 [TBL] [Abstract][Full Text] [Related]
39. Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease. Vassos E; Panas M; Kladi A; Vassilopoulos D Biol Psychiatry; 2007 Dec; 62(12):1347-52. PubMed ID: 17610848 [TBL] [Abstract][Full Text] [Related]
40. Rasagiline for the treatment of parkinsonism in Huntington's disease. Pérez-Pérez J; Martínez-Horta S; Pagonabarraga J; Carceller M; Kulisevsky J Parkinsonism Relat Disord; 2015 Mar; 21(3):340-2. PubMed ID: 25601128 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]